Yanna Liu

The status of compensated cirrhosis might be negatively associated with the tumor size in patients with hepatitis B virus-related hepatocellular carcinoma

Xiangmei Chen, Congying Wu, Jingmin Zhao, 2022, Global Translational Medicine.

Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

H. Xiang, Xianghui Qi, Jing-wen Ai, 2022, Hepatology International.

The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients

Xiangmei Chen, Y. Nan, S. Dang, 2022, Viruses.

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients

Jie Wang, L. Dai, S. Zheng, 2022, Emerging Microbes & Infections.

Dynamic changes of HBV pgRNA splicing variants and 3' terminal truncations affect the quantitative detection of serum HBV RNA.

Jie Wang, L. Dai, S. Zheng, 2022, Emerging microbes & infections.

Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients

Z. Duan, Zhongping Deng, S. Zheng, 2022, International journal of medical sciences.

Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study

H. Xiang, Xianghui Qi, Chuan Liu, 2022, Journal of medical virology.